Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here? by Khalil Mallah, Christine Couch, Christine Couch, Davis M. Borucki, Davis M. Borucki, Davis M. Borucki, Amer Toutonji, Amer Toutonji, Amer Toutonji, Mohammed Alshareef, Mohammed Alshareef, Stephen Tomlinson, Stephen Tomlinson

Get full text

Complement-Mediated Microglial Phagocytosis and Pathological Changes in the Development and Degeneration of the Visual System by Davis M. Borucki, Davis M. Borucki, Davis M. Borucki, Amer Toutonji, Amer Toutonji, Amer Toutonji, Christine Couch, Christine Couch, Khalil Mallah, Baerbel Rohrer, Baerbel Rohrer, Baerbel Rohrer, Stephen Tomlinson, Stephen Tomlinson

Get full text

Chronic complement dysregulation drives neuroinflammation after traumatic brain injury: a transcriptomic study by Amer Toutonji, Mamatha Mandava, Silvia Guglietta, Stephen Tomlinson

Get full text

Mass cytometric analysis of the immune cell landscape after traumatic brain injury elucidates the role of complement and complement receptors in neurologic outcomes by Amer Toutonji, Carsten Krieg, Davis M. Borucki, Mamatha Mandava, Silvia Guglietta, Stephen Tomlinson

Get full text

Evaluating the comorbidities of age and cigarette smoking on stroke outcomes in the context of anti-complement mitigation strategies by Christine Couch, Ali M. Alawieh, Amer Toutonji, Carl Atkinson, Stephen Tomlinson, Stephen Tomlinson

Get full text